Simplex Trading’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,400
| Closed | -$2K | – | 9782 |
|
|
2025
Q1 | $2K | Sell |
2,400
-4,500
| -65% | -$8.13K | ﹤0.01% | 8090 |
|
|
2024
Q4 | $6K | Buy |
6,900
+300
| +5% | +$373 | ﹤0.01% | 7545 |
|
|
2024
Q3 | $9K | Sell |
6,600
-1,300
| -16% | -$1.91K | ﹤0.01% | 7287 |
|
|
2024
Q2 | $10K | Buy |
7,900
+100
| +1% | +$152 | ﹤0.01% | 7455 |
|
|
2024
Q1 | $12K | Buy |
7,800
+2,900
| +59% | +$5.03K | ﹤0.01% | 7503 |
|
|
2023
Q4 | $9K | Sell |
4,900
-21,500
| -81% | -$40K | ﹤0.01% | 7538 |
|
|
2023
Q3 | $63K | Sell |
26,400
-11,300
| -30% | -$29.9K | ﹤0.01% | 5584 |
|
|
2023
Q2 | $96K | Sell |
37,700
-12,000
| -24% | -$31.7K | ﹤0.01% | 5138 |
|
|
2023
Q1 | $81K | Sell |
49,700
-516,600
| -91% | -$2.07M | ﹤0.01% | 5405 |
|
|
2022
Q4 | $1.55M | Buy |
566,300
+498,100
| +730% | +$1.45M | ﹤0.01% | 2067 |
|
|
2022
Q3 | $269K | Buy |
68,200
+65,100
| +2,100% | +$411K | ﹤0.01% | 4223 |
|
|
2022
Q2 | $17K | Sell |
3,100
-1,980
| -39% | -$16.5K | ﹤0.01% | 7788 |
|
|
2022
Q1 | $56K | Sell |
5,080
-7,120
| -58% | -$79.9K | ﹤0.01% | 6991 |
|
|
2021
Q4 | $178K | Sell |
12,200
-4,950
| -29% | -$108K | ﹤0.01% | 5360 |
|
|
2021
Q3 | $771K | Buy |
17,150
+10
| +0.1% | +$353 | ﹤0.01% | 3466 |
|
|
2021
Q2 | $795K | Buy |
17,140
+17,104
| +47,511% | +$824K | ﹤0.01% | 3468 |
|
|
2021
Q1 | $216K | Buy |
+36
| New | +$2.46K | ﹤0.01% | 4628 |
|
|
2020
Q2 | – | Sell |
-10
| Closed | -$59K | – | 8395 |
|
|
2020
Q1 | $59K | Buy |
+10
| New | +$630 | ﹤0.01% | 4967 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7006 |
|
|
2019
Q3 | – | Sell |
-8
| Closed | -$76K | – | 7925 |
|
|
2019
Q2 | $76K | Buy |
+8
| New | +$681 | ﹤0.01% | 4467 |
|
Simplex Trading's UBX Position: Q4 2025 in Review
Simplex Trading sold out of Unity Biotechnology (UBX) in Q4 2025, closing a stake of 2,571 shares.
Simplex Trading first reported a position in UBX in Q1 2019 and held it in 15 quarters. The position peaked at $133K in Q4 2021. 0 funds tracked by Wall St. Rank hold UBX as of Q4 2025.
- Simplex Trading reported no remaining Unity Biotechnology position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 2,571 Unity Biotechnology shares in Q4 2025.
- Simplex Trading first reported a position in Unity Biotechnology in Q1 2019 and held it in 15 quarters.
- Simplex Trading's Unity Biotechnology position peaked at $133K in Q4 2021.
- 0 funds tracked by Wall St. Rank held Unity Biotechnology as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.